Investors buckle up for pivotal Turkey elections

By Marc Jones and Canan Sevgili LONDON (Reuters) -Wild currency moves? Bazooka rate hikes? The many unknowns around Turkey’s pivotal elections on Sunday are leaving even the most experienced investors hedging their bets on how markets will react. The presidential vote, which could well require two rounds, is pitting President Tayyip Erdogan’s vision of a…

Read More

Hong Kong Q1 GDP grew 2.7% y/y, sees tourism, consumption driving recovery this year

HONG KONG (Reuters) -Hong Kong’s economy grew 2.7% in the first quarter from a year earlier, government data showed on Friday, thanks to a strong recovery of inbound tourism and domestic demand which would remain drivers for growth this year. It was the first quarter of growth after four consecutive ones of contraction. The city’s…

Read More

Pratt & Whitney says faces higher risks after Go First filed for bankruptcy

By Mike Scarcella and Jahnavi Nidumolu NEW YORK/BENGALURU (Reuters) -Pratt & Whitney on Thursday opposed Go Airlines (India) Ltd’s push to enforce an arbitration ruling in an engine dispute, with the U.S. company arguing in a Delaware court that the Indian airline’s bankruptcy filing has raised risks for it. The Indian airline, widely known as…

Read More

Rights group sues over Biden rule curbing asylum at U.S.-Mexico border

By Ted Hesson WASHINGTON (Reuters) – Immigration advocates represented by the American Civil Liberties Union (ACLU) filed a legal challenge on Thursday minutes before a U.S. regulation restricting access to asylum at U.S.-Mexico border was set to take effect. In a motion filed before a federal judge in California, the groups want to re-open an…

Read More

Philips to pay $62 million to resolve charges it violated US law

WASHINGTON (Reuters) -Dutch medical device maker Philips will pay $62 million (56 million euros) to resolve charges it violated the Foreign Corrupt Practices Act over its conduct related to sales of medical equipment to China, the U.S. Securities and Exchange Commission said on Thursday. Philips said the settlement related to allegations of “irregularities in the…

Read More

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

By Jennifer Rigby LONDON (Reuters) – New highly-effective weight loss drugs such as Novo Nordisk’s Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.    The…

Read More